News | August 04, 2022
Sandu Pharmaceuticals launches Sandu Kumarvin
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Sandu Kumarvin is an Ayurvedic digestive and immunity booster for children and also offers several other benefits.
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim
Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision
USFDA also approved complementary diagnostic imaging agent, Locametz, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions
ICICI Direct’s analysis of Cipla’s Q3FY22 results
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Subscribe To Our Newsletter & Stay Updated
